Table 4 Postoperative pain, recovery profiles and postoperative adverse effects
|  | Group A (n = 41) | Group B (n = 44) | Group C (n = 42) | Pvalue |
|---|---|---|---|---|
Postoperative 0–2 h |  |  |  |  |
  Pain (VRS) | 36 (0–80) | 41 (0–90) | 39 (0–100) | 0.974 |
  PCA consumption (ml) | 1.5 (0–7) | 1.5 (0–8) | 1.5 (0–5) | 0.921 |
Postoperative 2–24 h |  |  |  |  |
  Pain (VRS) | 27 (0–100) | 26 (0–85) | 26 (0–70) | 0.792 |
  PCA consumption (ml) | 11 (0–46) | 12 (20–75) | 13 (0–78) | 0.541 |
Postoperative 24–48 h |  |  |  |  |
  Pain (VRS) | 17 (0–80) | 15 (0–60) | 18(0–70) | 0.589 |
  PCA consumption (ml) | 16 (1–95) | 26 (0.2-100) | 22 (0–88) | 0.345 |
Advervse events | Â | Â | Â | Â |
  Drowsiness | 4 (10) | 5 (11) | 2 (5) | 0.528 |
  Dizziness | 7 (17) | 14 (32) | 6 (14) | 0.101 |
  Itching | 1 (2) | 1 (2) | 0 (0) | 0.604 |
  Others | 1 (2) | 0 (0) | 0 (0) | 0.347 |